"Cinnamon" is two different plants. Cassia is the bark of trees grown in China, Indonesia, and Vietnam; Ceylon (Cinnamomum verum) grows almost only in Sri Lanka 1. Cassia is hot and bold, Ceylon delicate and citrusy, and cassia carries coumarin at two to ten milligrams per gram against Ceylon's trace amount 2.
The blood-sugar claim is real but small. Cinnamon blunts the post-meal sugar spike and, in people with type-2 diabetes, gently lowers baseline glucose over weeks 3. Pooled across many trials, the long-term marker HbA1c drops about 0.27 points, roughly a fifth of what metformin does 4. It is a margin, not a treatment.
The whole protocol is one jar. If you use cinnamon at all often, this is a five-dollar decision you make once.
What the swap buys you. For most people, nothing you can feel: cinnamon just stops being something the supplement aisle sells at you, and the jar becomes one the household can use heavily without keeping milligram tallies. For anyone pre-diabetic or early type-2 watching the numbers, daily Ceylon nudges fasting glucose the same order of magnitude as losing five to seven pounds 5. It is not the plan. It is one small thing that compounds alongside the plan.
The fine print — when to skip it, and what people get wrong
Cinnamon is not a blood-sugar cure. One early trial showed a big drop 6; every meta-analysis since has shrunk it 5. For a healthy adult, the felt change is none.
The cassia ceiling. The safe coumarin limit is about seven milligrams a day for a 70 kg adult; a heaping teaspoon of cassia delivers ten to twenty-five 7. Case reports link cinnamon supplements to acute hepatitis that resolves on stopping 8. On metformin, a blood thinner, or insulin, tell your doctor before daily multi-gram use.
- 1Ranasinghe et al. (2013). Medicinal properties of 'true' cinnamon (Cinnamomum zeylanicum): a systematic review. BMC Complementary and Alternative Medicine. link
- 2Wang et al. (2013). Quantitative determination of coumarin in cinnamon by ultra-performance liquid chromatography-mass spectrometry. Journal of Agricultural and Food Chemistry. link
- 3Hlebowicz et al. (2007). Effect of cinnamon on postprandial blood glucose, gastric emptying, and satiety in healthy subjects. American Journal of Clinical Nutrition. link
- 4Deyno et al. (2019). Efficacy and safety of cinnamon in type 2 diabetes mellitus and pre-diabetes patients: A meta-analysis and meta-regression. Diabetes Research and Clinical Practice. link
- 5Allen et al. (2013). Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Annals of Family Medicine. link
- 6Khan et al. (2003). Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. link
- 7BfR (2012). New insights into coumarin contained in cinnamon — Updated BfR Opinion No. 036/2012. link
- 8Brancheau et al. (2015). Do cinnamon supplements cause acute hepatitis? American Journal of Case Reports. link
Cinnamon (Ceylon vs Cassia)
Three large meta-analyses (Allen 2013, Akilen 2012, Deyno 2019) confirm direction and rough magnitude of fasting-glucose reductions in T2D, but heterogeneity is high (I² > 80% in Deyno 2019), HbA1c signal is inconsistent across pooled analyses, and no major diabetes guideline endorses cinnamon. Mechanism plausible (insulin-receptor potentiation, gastric-emptying delay, α-glucosidase inhibition); cell-culture and rodent data strong, human dose-response unresolved.
Reproducible postprandial glucose blunting at 1–6 g per meal (Hlebowicz 2007; Magistrelli & Chezem 2012 — ~21% lower glucose AUC in normal-weight adults), with secondary symptomatic gain (less mid-afternoon glucose-related drowsiness). Real but small; mostly subclinical in healthy adults.
Meta-analytic fasting glucose reductions of ~19–25 mg/dL (Allen 2013; Deyno 2019) and HbA1c reductions of ~0.27% (Deyno 2019) translate into modest reductions in microvascular and cardiovascular event risk only when sustained in people with poorly controlled T2D; effect on population mortality is marginal at culinary doses.